History of the project
DisiAq® is available as a reproductive trigger by dint of a scientific project involving leading UK universities and research institutes, renowned zoos and other industrial and academic partners around the world. Work began in vertebrates (mammals), then continued in invertebrates (nematode worms), before returning to vertebrates.
The initial focus of the work was a potential new anticancer drug. To check out the compound’s wider biology the research had ‘dropped down’ into a species of nematode, Caenorhabditis elegans. This is a tiny roundworm found in soil. It shares half our genes and has a usefully short life cycle. C. elegans is a model organism in research.
To the team’s surprise the worms had more offspring than expected. But this wasn’t a drug effect at all. This was among controls which had received only a tiny amount of a complex combination of foodstuffs by way of comparison, in addition to their normal food (bacteria). The drug was forgotten and the intriguing foodstuffs taken forward, in what has become a piece of ‘off road science’. The result is DisiAq, available from www.disiaq.com.
Molecular modelling has shown that DisiAq’s mechanism of action appears unlike that of pharmaceutical products – which are drug ‘keys’ fitting into receptor ‘locks’, within the so-called ligand-receptor paradigm. Something more elusive and mysterious is going on, the net effect of which is that DisiAq seems to be a stimulator of the organism’s nutrient response pathway in the context of reproduction. Of possible relevance in this context is the presence of taste buds in the digestive tract and elsewhere, acting as disseminated sensors of the classical elements of taste perception (bitter, sweet, umami etc). In this interpretation DisiAq gives organisms a taste for breeding.
DisiAq mostly comprises multiple micro nutrients in a synergistic low-dose combination at an optimised ratio. The majority are naturally occurring entities, though some are synthetic versions thereof. An attempt was made to simplify the supplement down to just three components, but the reproductive effect was lost.
The product has proved safe and efficacious (i.e. it has worked without toxicity) across multiple species, both invertebrate (e.g. nematodes and molluscs) and vertebrate (e.g. fish and amphibians). DisiAq has yet to be tested in mammals, but there is an expectation of enhanced reproduction in this class of animals too, given that the response to the product seems evolutionarily conserved.
Results with the kit have not so far been published (though case studies are available at www.disiaq.com/casestudies) to preserve the DisiAq formulation as proprietary information. Optimal use characteristics have been meticulously embodied in the kit design, without disclosure. If you use the kit, please follow carefully the (simple) instructions in the pack leaflet. Above all, do not expose the supplement to strong light prior to adding the liquid to the solid.
DisiAq is believed to be the first commercially available aphrodisiac that has been subjected to third-party research validation. The health & safety status of this product is 'No hazards known, predicted, detected or likely; non-toxic’. The final product is benign but the production process to derive it is paradoxically exacting, involving intense cold and darkness. Quality control is of the absolute essence.
The DisiAq logo includes a pinecone, an ancient symbol of regeneration and fertility. The logo on this site features a new symbol, representing fecundity.
DisiAq® is a UK registered trade mark, No. 2625612.
Mestizaje es grandeza (‘Mixture is greatness’, Spanish saying)
